Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China

Journal of Infection

Volumn 63, Issue 6, 2011, Pages 441-446

  Zhang, Qi ^a   Han, Fulian ^b   Nie, Qing ^b   Ren, Hongyu ^a   Zhang, Baoqiang ^b   Liu, Qiyong ^a   He, Qiushui ^c   Shao, Zhujun ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Weifang Municipal Center for Disease Control and Prevention   (China)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

China; Cross sectional study; Diptheria; Pertussis; Seroprevalence

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA ANTIBODY; DIPHTHERIA TOXIN; DIPHTHERIA VACCINE; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; SEROPREVALENCE; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTITOXINS; CHINA; CROSS-SECTIONAL STUDIES; DIPHTHERIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; WHOOPING COUGH; YOUNG ADULT;

EID: 82255174975     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.07.018     Document Type: Article

References (44)

1. Immunization profile - China 2010, WHO, 12.
2. Lartigue M.F.M.X., Le Flèche A., Grimont P.A., Benet J.J., Durrbach A., Fabre M., et al. Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol 2005, 43(2):999-1001.
3. Tiwari T.S.G.A., Yu D.T., Ehresmann K.R., Jones T.F., Hill H.E., Cassiday P.K., et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008, 46(3):395-401.
4. Tan T., Trindade E., Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005 May, 24(5 Suppl):S10-S18.
5. Cherry J.D., Grimprel E., Guiso N., Heininger U., Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005 May, 24(5 Suppl):S25-S34.
6. Forsyth K.T.T., von König C.H., Caro J.J., Plotkin S. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 2005, 24(5 Suppl):S69-S74.
7. Ward Joel I., Cherr James D., Chang Swei-Ju, Partridge Susan, Lee Hang, Treanor John, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. New Engl J Med 2005, 353(15):1555-1563.
8. Edwards K., Freeman D.M. Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr 2006 Feb, 18(1):77-80.
9. Forsyth K.D., Wirsing von Konig C.H., Tan T., Caro J., Plotkin S. Prevention of pertussis: recommendations derived from the second global pertussis initiative roundtable meeting. Vaccine 2007 Mar, 25(14):2634-2642.
10. Meeting of the strategic advisory group of experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009, 84:517-532. WHO.
11. Jian F., Yue-fang W., Bao-xiang X. Analysis on pertussis epidemiology in Zhejiang Province in 1954-2004. Chin J Vaccines Immunization 2005, 11(4):279-281.
12. Yan Y., Lin-qi D., Zhen-yuan S. Analysis on epidemiology in 1963-2002 and control strategy on pertussis in Henan Province. Chin J Vaccines Immunization 2005, 11(5):402-404.
13. Cheng-yan M., Wen-hong Z. Current status and perspective of worldwide disease burden of pertussis. Chin J Vaccines Immunization 2006, 12(4):318-321.
14. Campins-Martí M.C.H., Forsyth K., Guiso N., Halperin S., Huang L.M., Mertsola J., et al. International consensus group on pertussis immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001, 20(5-6):641-646.
15. Muller F.M., Hoppe J.E., Wirsing von Konig C.H. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997 Oct, 35(10):2435-2443.
16. Schmitt-Grohe S., Cherry J.D., Heininger U., Uberall M.A., Pineda E., Stehr K. Pertussis in German adults. Clin Infect Dis 1995 Oct, 21(4):860-866.
17. Hodder S.L., Cherry J.D., Mortimer E.A., Ford A.B., Gornbein J., Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 2000 Jul, 31(1):7-14.
18. Cattaneo L.A., Reed G.W., Haase D.H., Wills M.J., Edwards K.M. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996 May, 173(5):1256-1259.
19. Arav-Boger R., Ashkenazi S., Gdalevich M., Cohen D., Danon Y.L. Seroprevalence of pertussis antibodies among adolescents in Israel. Isr Med Assoc J 2000, 2(2):174-177.
20. Okada K., Ueda K., Morokuma K., Kino Y., Tokugawa K., Nishima S. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program. Jpn J Infect Dis 2004 Apr, 57(2):67-71.
21. Wilder-Smith A., Ng S., Earnest A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore 2006 Nov, 35(11):780-782.
22. Hashemi S.H., Ranjbar M., Hajilooi M., Seif-Rabiei M.-A., Bolandi M., Moghimi J. Seroprevalence of immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis 2009, 9(9):1-4.
23. Syed M.A., Said F., Bukhari S.H.A. Seroepidemiology of Bordetella pertussis infections in the twin cities of Pakistan. North Am J Med Sci 2009, 1(7):353-355.
24. Audun Aase T.K.H., Merino Samuel, Torkildsen Brandsdal Kari, Peter Berdal Bjørn, Aleksandersen Erja M., Aaberge Ingeborg S. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway. Clin Vaccine Immunol 2007, 14(7):855-862.
25. Deville J.G., Cherry J.D., Christenson P.D., Pineda E., Leach C.T., Kuhls T.L., et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995 Sep, 21(3):639-642.
26. Heininger U., Kleemann W.J., Cherry J.D. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004 Jul, 114(1):e9-e15.
27. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von Konig C.H. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2010 Mar, 30(3):307-312.
28. Maple P.A., Efstratiou A., George R.C., Andrews N.J., Sesardic D. Diphtheria immunity in UK blood donors. Lancet 1995 Apr 15, 345(8955):963-965.
29. Ballereau F., Schrive I., Fisch A., Speich M., Laurichesse H., Tournade S., et al. A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects. Eur J Epidemiol 1998 Jul, 14(5):499-503.
30. de Melker H.E., Berbers G.A., Nagelkerke N.J., Conyn-van Spaendonck M.A. Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis 1999 Sep-Oct, 5(5):694-700.
31. Marlovits S., Stocker R., Efstratiou A., Broughton K., Kaider A., Vecsei V., et al. Seroprevalence of diphtheria immunity among injured adults in Austria. Vaccine 2000 Dec 8, 19(9-10):1061-1067.
32. von Hunolstein C., Rota M.C., Alfarone G., Ricci M.L., Salmaso S. Diphtheria antibody levels in the Italian Population. Eur J Clin Microbiol Infect Dis 2000 Jun, 19(6):433-437.
33. Redwan E.M., El-Awady M.K. Status of diphtheria immunity in the Egyptian population. Ann Trop Med Parasitol 2005 Jan, 99(1):93-99.
34. Valinsky L., Simhoni S., Bassal R., Agmon V., Yishai R., Green M.S., et al. Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel. Clin Microbiol Infect 2006 Oct, 12(10):968-973.
35. Kjeldsen K., Simonsen O., Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet 1985 Apr 20, 1(8434):900-902.
36. Wen-sheng W., Ai-hua L., Yin-hua G. Surveillance and analysis of diphtheria antibody in healthy population during 1996-2000 in Beijing. Zhongguo Ji Hua Mian Yi 2002, 8(5):264-265.
37. Huang L.M., Xu E.P., Yang L.X. Observation of immunity level of pertussis-diphtheria-tetanus in healthy people in Hangzhou City during 1995-2006. Zhongguo Ji Hua Mian Yi 2009 Feb, 15(1):68-71.
38. Schneerson R., Robbins J.B., Taranger J., Lagergard T., Trollfors B. A toxoid vaccine for pertussis as well as diphtheria? lessons to be relearned. Lancet 1996 Nov 9, 348(9037):1289-1292.
39. Diphtheria vaccine-WHO position paper. Wkly Epidemiol Rec 2006, 81(3):21-32. WHO.
40. Rappuoli R., Perugini M., Falsen E. Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden. N Engl J Med 1988 Jan 7, 318(1):12-14.
41. Expanded programme on immunization. diphtheria and measles control, China. Wkly Epidemiol Rec 1988, 63:225-227. WHO.
42. Galazka A.M., Robertson S.E. Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol 1995 Feb, 11(1):107-117.
43. Zhang R.Z., Wang K.A., Wang H. Seroepidemiological surveillance and methodological study of pertussis, diphtheria and tetanus. Zhonghua Liu Xing Bing Xue Za Zhi 1995 Aug, 16(4):223-227.
44. Xing D., Wirsing von Konig C.H., Newland P., Riffelmann M., Meade B.D., Corbel M., et al. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol 2009 Mar, 16(3):303-311.